Abstract:Hypoxia has been firmly correlated to the drug resistance of solid tumors. Alleviation of hypoxia by tumor reoxygenation is expected to sensitize the chemotherapy toward solid tumors. Alternatively, ferroptosis provides a therapeutic strategy to overcome apoptotic resistance and multidrug resistance of solid tumors, collaboratively strengthening the chemotherapy toward hypoxic tumors. Herein, an ultrasound (US)-activatable nanomedicine was developed for overcoming hypoxia-induced resistance to chemotherapy and efficiently inhibiting tumor growth by inducing sensitized apoptosis and collaborative ferroptosis of tumor cells. This nanomedicine was constructed by integrating ferrate and doxorubicin into biocompatible hollow mesoporous silica nanoplatforms, followed by assembling a solid-liquid phase-change material of n-heneicosane. The US-induced mild hyperthermia initiates the phase change of n-heneicosane, enabling US-activated co-release of ferrate and doxorubicin. Results reveal that the released ferrate effectively reacts with water as well as the over-expressed hydrogen peroxide and glutathione in tumor cells, achieving tumor-microenvironment-independent reoxygenation and glutathione-depletion in tumors. The reoxygenation down-regulates expressions of hypoxia-inducible factor 1α and multidrug resistance gene/transporter P-glycoprotein in tumor cells, sensitizing the apoptosis-based doxorubicin chemotherapy. More importantly, exogenous iron metabolism from the nanomedicine initiates intracellular Fenton reactions, leading to reactive oxygen species overproduction and iron-dependent ferroptotic death of tumor cells. Furthermore, the glutathione-depletion inactivates the glutathione peroxidase 4 (GPX4, a critical regulatory target in ferroptosis), inhibiting the reduction of lipid peroxides and reinforcing the ferroptotic cell death. The sensitized chemotherapy together with the iron-dependent ferroptosis of tumor cells play a synergistic role in boosting the growth suppression of hypoxic osteosarcoma in vivo. Additionally, the nanomedicine acts as a nanoprobe for in vivo photoacoustic imaging and glutathione tracking, showing great potential as theranostic agents for hypoxic solid tumors treatment.

Polydopamine-coated UiO-66 Nanoparticles Loaded with Perfluorotributylamine/tirapazamine for Hypoxia-Activated Osteosarcoma Therapy

Porphyrin‐Based Porous Organic Frameworks As Oxygen Reservoirs to Overcome Tumor Hypoxia for Enhanced Photodynamic Therapy

Polydopamine-cloaked Fe-based metal organic frameworks enable synergistic multidimensional treatment of osteosarcoma

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

A dual-response drug delivery system with X-ray and ROS to boost the anti-tumor efficiency of TPZ <i>via</i> enhancement of tumor hypoxia levels

Photodynamic-therapy and Chemotherapy of TPBC-PEG Nanoplatform Encapsulated Triptolide Synergistically Inhibit Primary Osteosarcoma Growth and Pulmonary Metastasis by Activating HIPPO Signaling

Hypoxia Inhibitor Combined with Chemotherapeutic Agents for Antitumor and Antimetastatic Efficacy against Osteosarcoma

Polydopamine-modified ZIF-8 Nanoparticles As a Drug Carrier for Combined Chemo-Photothermal Osteosarcoma Therapy

Iron-polydopamine Coated Multifunctional Nanoparticle SiO2@PDA/Fe3+- FA Mediated Low Temperature Photothermal for Chemodynamic Therapy of Cisplatin-Insensitive Osteosarcoma

Oxygenated Theranostic Nanoplatforms with Intracellular Agglomeration Behavior for Improving the Treatment Efficacy of Hypoxic Tumors

Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies

Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors

Perfluorocarbon@Porphyrin Nanoparticles For Tumor Hypoxia Relief To Enhance Photodynamic Therapy Against Liver Metastasis Of Colon Cancer

OXPHOS-targeted nanoparticles for boosting photodynamic therapy against hypoxia tumor

Liposome Encapsulated Polydopamine Nanoparticles: Enhancing Ferroptosis and Activating Hypoxia Prodrug Activity

Fluorocarbon‐Functionalized Polymerization‐Induced Self‐Assembly Nanoparticles Alleviate Hypoxia to Enhance Sonodynamic Cancer Therapy

TaOx Decorated Perfluorocarbon Nanodroplets As Oxygen Reservoirs to Overcome Tumor Hypoxia and Enhance Cancer Radiotherapy

Photothermally Reinforced Chemodynamic Therapy in the Treatment of Osteosarcoma by Polydopamine-Modified, Copper Peroxide Loaded ZIF8 Nanoparticles

GE11-PDA-Pt@USPIOs Nano-Formulation for Relief of Tumor Hypoxia and MRI/PAI-guided Tumor Radio-Chemotherapy

Biomimetic Engineered Nanoparticles Target Drug-Resistant Tumor Cells and Heterogeneous Blood Vessels for Combination Therapy of Osteosarcoma

Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy